Consumer telehealth · Online menopause care
Evernow
Evernow is an online menopause practice where menopause-trained clinicians treat symptoms with hormone therapy, non-hormonal medications, and weight care, with insurance accepted for video visits.
Strong fit
- Women in perimenopause or menopause who want to use insurance for visits
- Patients who want ongoing care from a menopause-trained clinician
- Women who want hormone therapy, non-hormonal options, or weight care in one place
Weak fit
- Medicare and Medicaid patients who need coverage
- Women who want in-person exams
- People who want care with no membership fee
Bottom line
Evernow is an online menopause practice with menopause-trained clinicians, unlimited messaging, and insurance-covered video visits. It suits women with commercial insurance who want ongoing hormone and symptom care in any state. Medicare and Medicaid patients cannot use their coverage.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Dr. Alicia Jackson founded Evernow after serving as deputy director of DARPA's Biological Technologies Office. She holds a PhD from MIT and co-founded Drawbridge Health with GE. She first set out to build a fertility company before turning to menopause.
Patients complete an intake and are matched with a menopause-trained clinician licensed in their state. Members get unlimited secure messaging, optional video visits, and a care portal for their plan and refills. Evernow treats patients in all 50 states and Washington, DC.
Plans can include hormone therapy, non-hormonal medications, vaginal estrogen cream, and weight care. Prescriptions go to a local pharmacy, where insurance often applies, or ship from Evernow partner pharmacies for cash.
Evernow takes major commercial insurance for video visits, though membership fees are not covered. HSA and FSA cards work for membership. Pay-per-visit care gives 90 days of portal access for short-term needs such as a second opinion.
Evernow says more than 100,000 women took part in its menopause study. Investors in its $28.5 million round in 2022 included Gwyneth Paltrow and Cameron Diaz.
Alloy fits women who want a simple cash price and care mostly by message. Allara Health fits women whose hormone questions overlap with thyroid, PCOS, or metabolic care. Mochi Health fits patients whose main goal is weight care, with menopause treatment added.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Allara Health | 7.7 | 7.8 |
| Evernow | 7.6 | 7.9 |
| Alloy | 7.4 | 8.0 |
| Mochi Health | 7.0 | 6.6 |
Pricing
| Item | Detail |
|---|---|
| Model | Evernow sells a membership with unlimited messaging, or pay-per-visit care. |
| What usually drives cost | For Evernow, cost depends on the membership length you choose, whether your insurance covers video visits, and which medications you take and where you fill them. |
| What to ask before you buy | Ask Evernow whether your plan covers its video visits, what your medications cost at your pharmacy versus its partner pharmacies, and how renewal works. |
| Note | Evernow takes UnitedHealthcare, Aetna, Anthem, and Blue Cross Blue Shield for video visits, but not Medicare or Medicaid. |
| Published pricing | Evernow lists membership at $129 for 3 months or $420 for 12 months, which works out to $35 a month. Self-pay video visits cost $150. |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.